Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis
GlaxoSmithKline (Belgium) · University of Edinburgh · +1 more institution
Abstract
Respiratory syncytial virus (RSV)-associated acute respiratory infection (ARI) is an underrecognized cause of illness in older adults. We conducted a systematic literature review and meta-analysis to estimate the RSV disease burden in adults ≥60 years in high-income countries.
Data on RSV-ARI and hospitalization attack rates and in-hospital case fatality rates (hCFR) in adults ≥60 years from the United States, Canada, European countries, Japan, and South Korea were collected based on a systematic literature search (January 1, 2000-November 3, 2021) or via other methods (citation search, unpublished studies cited by a previous meta-analysis, gray literature, and an RSV-specific abstract booklet). A random effects meta-analysis was performed on estimates from the included studies.
Citation impact
- FWCI
- 49.99
- Percentile
- 100%
- References
- 43
Authors
5Topics & keywords
- Medicine
- Meta-analysis
- Case fatality rate
- Confidence interval
- Pediatrics
- Disease burden
- Systematic review
- Disease